Patients
Sites
Sponsors
About Us
News
Sites access
Onco access
EN
Last updated 55 days ago
Share
Effect of Botulinum Toxin Type A on Motor Function in Children With Cerebral Palsy
30 patients around the world
Available in
Chile
Instituto Teletón Chile
1
Research sites
30
Patients around the world
This study is for people with
Cerebral Palsy
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Inclusion criteria
Spastic hemiparesis type Cerebral Palsy.
Gross Motor Classification System I-II.
Age 8 to 17 years based on validation ages for scales to be used.
Minimum of 6 months since last botulinum toxin injection.
Informed consent signed by legal guardian and assent from users aged 12 to 17 years.
Exclusion criteria
Cognitive impairment that prevents following instructions for functional assessments.
Limitation of joint range not caused by spasticity.
Patients diagnosed with other diseases causing spasticity different from cerebral palsy.
Patients with other neuromuscular diseases.
Sites
Instituto Teletón
Consult
View site
Av. Alameda Libertador Bernardo O'Higgins 4620, 9190015 Estación Central, Región Metropolitana, Chile
View site
Consult
See details
Contact us
Contact us
Sponsor
Instituto Teletón Chile
Study type
Interventional
Conditions
Cerebral Palsy
Requirements
To 17 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT07034547
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent